Publication Name	World Journal of Gastroenterology
Manuscript ID	17597
Country	Greece

Received	2015-03-14 13:58
Peer-Review Started	2015-03-16 14:58
First Decision by Editorial Office Director
Return for Revision	2015-05-20 19:54
Revised	2015-05-27 02:29
Publication Fee Transferred
Second Decision by Editor	2015-07-17 17:08
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2015-07-18 11:13
Articles in Press	2015-07-18 11:13
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-08-11 16:20
Publish the Manuscript Online	2015-08-28 17:04

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients
Manuscript Source	Invited Manuscript
All Author List	Evangelos Cholongitas, Chrysoula Pipili and George Papatheodoridis
Funding Agency and Grant Number
Corresponding Author	Evangelos Cholongitas, Assistant Professor of Internal Medicine, 4th Department of Internal Medicine, Medical School of Aristotle University, Hippokration General Hospital of Thessaloniki, 49, Konstantinopoleos Street, 54642 Thessaloniki, Greece. cholongitas@yahoo.gr
Key Words	Hepatitis C; Direct acting antiviral agents; Liver transplantation; Decompensated cirrhosis; Sofosbuvir
Core Tip	Treatment against hepatitis C virus has dramatically improved with the novel direct-acting antivirals (DAAs). The currently available DAAs are sofosbuvir, simeprevir, daclatasvir, ledipasvir/sofosbuvir, paritaprevir/ombitasvir and dasabuvir. IFN-free combinations of these novel DAAs with or without ribavirin give excellent sustained virological response in patients with decompensated cirrhosis awaiting liver transplantation and those with recurrence of hepatitis C post liver transplantation. More data regarding the safety and efficacy of these new DAAs are needed, but ongoing clinical trials and real life data will clarify better these issues.
Publish Date	2015-08-28 17:04
Citation	Cholongitas E, Pipili C, Papatheodoridis G. Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients. World J Gastroenterol 2015; 21(32): 9526-9533
URL	http://www.wjgnet.com/1007-9327/full/v21/i32/9526.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i32.9526

Full Article (PDF)	WJG-21-9526.pdf
Full Article (Word)	WJG-21-9526.doc
Manuscript File	17597-Review.docx
Answering Reviewers	17597-Answering reviewers.pdf
Audio Core Tip	17597-Audio core tip.MP3
Conflict-of-Interest Disclosure Form	17597-Conflict-of-interest statement.pdf
Copyright License Agreement	17597-Copyright assignment.pdf
Peer-review Report	17597-Peer-review(s).pdf
Scientific Misconduct Check	17597-Scientific misconduct check.pdf
Scientific Editor Work List	17597-Scientific editor work list.pdf